Hospital Acquired Pneumonia
Non-ICU Patient

Non-ICU Patient

Management

Consider treatment modification if patient is at risk of resistant organisms (i.e. recent antimicrobial therapy or structural lung disease, prior culture)

Tailor antibiotic therapy based on culture results

Consider discontinuation of antibiotics, if alternative, non-infectious diagnosis is made

If patient is immunocompromised or recent travel history, patient may be at risk of unusual or opportunistic pathogens, Consider Infectious Disease Consult

Treatment

OR

OR

  • If SEVERE Beta-lactam allergy
  • Use IV if unable to take PO

IF MRSA RISK FACTORS, ADD

Per order set

Duration

  • 7 Days
  • Can consider longer duration of treatment for immunocompromised patients or in certain clinical conditions depending on rate of improvement of clinical parameters

Consider safe transition to oral therapy once:

  • Hemodynamically stable
  • Improving clinically
  • Afebrile for 24 hrs.
  • Can ingest oral meds and have functioning GI tract